Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Search

Total 27 results found. Search for [ dilip sanghvi ]

Results 1 to 21 of 27
PTI
February 1, 2018



Team BT
New Delhi, December 28, 2017
Top corporate honchos share their success stories


BT Online
New Delhi, September 13, 2016
The rise in his wealth can be attributed to Chinese e-commerce behemoth Alibaba's investment in the company and subsequent funding rounds that have raised Paytm's valuation.


Anand Adhikari
August 26, 2015
It has given licences to 11 entities for opening payments banks to widen the financial inclusion net and bring small payments like remittances, utility bills, ticketing, etc, under the digital umbrella.


Yoshita Singh
New York, August 20, 2015
Fast moving consumer goods company Hindustan Unilever has been ranked 41, followed by TCS at rank 64 and Sun Pharma at rank 71 in the Forbes list of The Worlds Most Innovative Companies which has been topped by the Elon Musk-led Tesla Motors.


PTI
Hyderabad, July 31, 2015
The firm's research arm - Sun Pharma Advanced Research Company - is currently working on three new drugs that are currently under clinical trial stage.


PTI
New Delhi, May 9, 2015
Competition Commission has cleared billionaire Dilip Shanghvi's proposed Rs 1,800 crore stake buy in wind turbine maker Suzlon Energy.


PTI
New Delhi, April 22, 2015
Sun Pharmaceuticals has clarified, amid speculations, that the company promoter has not purchased any shares on sale from Daiichi Sankyo's stake.


PB Jayakumar
March 26, 2015
Soon Ranbaxy Laboratories will cease to exist as the company is merging with Sun Pharmaceutical Industries.


P.B. Jayakumar
March 3, 2015
The deal does many things for Suzlon. It infuses Rs 1,800 crore of much-needed cash at a time its quarterly net loss is 17 times its sales. Secondly, it brings Sun Pharma's Dilip Shanghvi into the mix.


BT Online Bureau
New Delhi, February 20, 2015
If one adds the 23 per cent stake in Suzlon, that Shanghvi and his family is in the process of acquiring, his wealth would be nearly Rs 1.48 lakh crore, says the report.


Mail Today Bureau
New Delhi, February 18, 2015
Debt-laden Suzlon last week posted consolidated net loss of Rs 6,538.68 crore for the third quarter as against loss of Rs 1,075.25 crore in the year-ago period.


PTI
Mumbai, February 14, 2015
Its total income declined marginally to Rs 4,977.18 crore during the October-December quarter as against Rs 5,052.2 crore in the third quarter of FY14.


Aman Shah
Mumbai, February 14, 2015
The deal will provide Suzlon with much needed liquidity and the company said it would also use the cash to tap opportunities in India and growth markets like the US and China.


Manoj Kohli
December 23, 2014
Manoj Kohli, managing director of Bharti Enterprises writes on how India can change its image to a business-friendly economy for the rest of the world.


Zeba Siddiqui
Mumbai, October 28, 2014
The generic drugmaker has reported a profit of Rs 4.78 billion ($78 million), compared with a loss of Rs 4.5 billion a year earlier.


Abhishek Vishnoi
Mumbai, September 12, 2014
Shares of the drug maker fell over 4 per cent amid reports that the company's unit, Taro Pharmaceutical Industries, has recalled two lots of a key drug in US on September 2.


PTI
New Delhi, August 13, 2014
Ambani is followed by steel tycoon Lakshmi Mittal, drugmaker Sun Pharma's Dilip Shanghvi, IT giant Wipro's Azim Premji and Tata Sons' shareholder Pallonji Shapoorji Mistry among the top-five wealthiest individuals from India.


PTI
New Delhi, July 21, 2014
The 'no-objection' from the bourses will allow the two companies to file their scheme of amalgamation with the High Court for further clearance of the deal. Sun Pharma and Ranbaxy also require clearance from the competition regulator, among others.


Sumeet Chatterjee
Mumbai, July 16, 2014
Pharmalucence has sterile injectable capacity and research capabilities. Financial details of the deal were not disclosed.


PAGES 1 OF 2  12